Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Thromboprophylaxis After Surgery for Gynecologic Malignancy in China

NCT02935530 is registered in ClinicalTrials.gov with Huazhong University of Science and Technology as lead sponsor.

NCT NCT02935530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02935530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Thromboprophylaxis After Surgery for Gynecologic Malignancy in China
Lead sponsor
Huazhong University of Science and Technology
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2016
Completion date
October 31, 2017
Enrollment
315 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

argatroban, gynecologic neoplasms, low molecular weight heparin, venous thromboembolism